Related Experiment Videos
[Intestinal lymphagiectasis. Use of immunoregulators]
Boletin Medico Del Hospital Infantil De Mexico
|May 1, 1980
Summary
This study details a patient with intestinal lymphangiectasis, highlighting successful treatment with mebendazole, sulfasalazine, and calcium. The therapy led to increased immunoglobulins and leukocytes, improving diarrhea.
Area of Science:
- Gastroenterology
- Immunology
- Internal Medicine
Background:
- Intestinal lymphangiectasis is a rare condition characterized by dilation of lymphatic vessels in the small intestine.
- It can lead to protein-losing enteropathy, malabsorption, and immune dysfunction.
Observation:
- A case study of a patient diagnosed with intestinal lymphangiectasis.
- The patient presented with significant diarrheal symptoms.
Findings:
- Treatment involved a combination of mebendazole, sulfasalazine (also known as sulfazalopyridine), and oral calcium supplementation.
- Following treatment, there was a notable increase in immunoglobulin levels and T and B lymphocyte counts.
- Clinical improvement was observed, particularly in the resolution of diarrhea.
Implications:
- This immunologic treatment approach may be effective for managing intestinal lymphangiectasis.
- Further research into the immunomodulatory effects of this therapeutic combination is warranted.
- The findings suggest a link between lymphatic integrity and immune cell populations in the gut.